Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Racemic Ketamine Versus Esketamine (Spravato®) for Depression

NCT06713616 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06713616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06713616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Racemic Ketamine Versus Esketamine (Spravato®) for Depression
Lead sponsor
Yale University
Phase
Phase 3
Overall status
Recruiting
Start date
January 27, 2025
Completion date
December 31, 2030
Enrollment
400 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

depression